David Olmos, The Drug Development Unit, Royal Marsden National Health Services Foundation Trust and The Institute of Cancer Research, Surrey, United Kingdom Charles Swanton, Cancer Research UK Translational Cancer Therapeutics Laboratory, London Research Institute, London, United Kingdom Johann de Bono, The Drug Development Unit, Royal Marsden National Health Services Foundation Trust and The Institute of Cancer Research, Surrey, United Kingdom
No takes yet. Share an insight, caveat, or question.
Olmos et al. (2008) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: